Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.04
+0.04 (0.36%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Roivant Sciences Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Revenue | 122.59 | 124.8 | 61.28 | 55.29 | 23.8 | 67.69 | Upgrade
|
| Revenue Growth (YoY) | 140.04% | 103.65% | 10.84% | 132.34% | -64.85% | 2812.61% | Upgrade
|
| Cost of Revenue | 592.12 | 517.3 | 538.34 | 469.1 | 238.68 | 264.35 | Upgrade
|
| Gross Profit | -469.54 | -392.5 | -477.06 | -413.82 | -214.89 | -196.66 | Upgrade
|
| Selling, General & Admin | 749.13 | 687.44 | 600.51 | 425.03 | 259.88 | 335.77 | Upgrade
|
| Operating Expenses | 749.13 | 687.44 | 600.51 | 425.03 | 259.88 | 335.77 | Upgrade
|
| Operating Income | -1,219 | -1,080 | -1,078 | -838.85 | -474.77 | -532.43 | Upgrade
|
| Interest Expense | -34.78 | -34.78 | -27.97 | -7.04 | -2.81 | -7.68 | Upgrade
|
| Interest & Investment Income | 287.21 | 146.43 | 32.18 | 0.37 | 1.42 | 17.99 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -3.75 | -21.39 | Upgrade
|
| Other Non Operating Income (Expenses) | -39.56 | -85.03 | -62.19 | 73.06 | -33.41 | 11.18 | Upgrade
|
| EBT Excluding Unusual Items | -1,006 | -1,053 | -1,136 | -772.46 | -513.31 | -532.33 | Upgrade
|
| Gain (Loss) on Sale of Investments | 58.19 | -47.97 | -20.82 | 356.46 | 95.53 | -136.01 | Upgrade
|
| Gain (Loss) on Sale of Assets | 125.81 | 5,381 | 29.28 | 5.04 | 115.36 | 107.34 | Upgrade
|
| Other Unusual Items | -71.9 | - | - | -372.9 | - | - | Upgrade
|
| Pretax Income | -893.69 | 4,253 | -1,225 | -923.75 | -898.55 | -560.99 | Upgrade
|
| Income Tax Expense | -6.2 | 22.22 | 5.19 | 0.37 | 1.69 | 7.12 | Upgrade
|
| Earnings From Continuing Operations | -887.49 | 4,231 | -1,230 | -924.12 | -900.23 | -568.11 | Upgrade
|
| Earnings From Discontinued Operations | 600.64 | - | 114.56 | - | - | 1,578 | Upgrade
|
| Net Income to Company | -286.86 | 4,231 | -1,115 | -924.12 | -900.23 | 1,010 | Upgrade
|
| Minority Interest in Earnings | 170.23 | 117.72 | 106.43 | 78.85 | 91 | 190.19 | Upgrade
|
| Net Income | -116.62 | 4,349 | -1,009 | -845.26 | -809.23 | 1,201 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 77.78 | Upgrade
|
| Net Income to Common | -116.62 | 4,349 | -1,009 | -845.26 | -809.23 | 1,123 | Upgrade
|
| Shares Outstanding (Basic) | 749 | 783 | 713 | 670 | 630 | 219 | Upgrade
|
| Shares Outstanding (Diluted) | 749 | 831 | 713 | 670 | 630 | 219 | Upgrade
|
| Shares Change (YoY) | -6.79% | 16.59% | 6.43% | 6.30% | 187.64% | 4.93% | Upgrade
|
| EPS (Basic) | -0.16 | 5.55 | -1.42 | -1.26 | -1.28 | 5.13 | Upgrade
|
| EPS (Diluted) | -0.16 | 5.23 | -1.42 | -1.26 | -1.28 | 5.13 | Upgrade
|
| Free Cash Flow | -779.48 | -766.65 | -856.08 | -695.17 | -557.94 | -763.67 | Upgrade
|
| Free Cash Flow Per Share | -1.04 | -0.92 | -1.20 | -1.04 | -0.89 | -3.49 | Upgrade
|
| Gross Margin | - | - | - | - | - | -290.53% | Upgrade
|
| Operating Margin | -994.14% | -865.37% | -1758.43% | -1517.29% | -1995.23% | -786.58% | Upgrade
|
| Profit Margin | -95.14% | 3484.86% | -1646.59% | -1528.89% | -3400.86% | 1658.66% | Upgrade
|
| Free Cash Flow Margin | -635.87% | -614.33% | -1397.00% | -1257.40% | -2344.80% | -1128.20% | Upgrade
|
| EBITDA | -1,199 | -1,058 | -1,059 | -832.92 | - | - | Upgrade
|
| D&A For EBITDA | 19.7 | 22.04 | 18.86 | 5.93 | - | - | Upgrade
|
| EBIT | -1,219 | -1,080 | -1,078 | -838.85 | -474.77 | -532.43 | Upgrade
|
| Effective Tax Rate | - | 0.52% | - | - | - | - | Upgrade
|
| Revenue as Reported | 124.8 | 124.8 | 61.28 | 55.29 | - | - | Upgrade
|
Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.